Transcatheter Arterial Chemoembolization for Hepatic Recurrence after Curative Resection of Pancreatic Adenocarcinoma.
- Author:
Jin Hyoung KIM
1
;
Eugene K CHOI
;
Hyun Ki YOON
;
Gi Young KO
;
Kyu Bo SUNG
;
Dong Il GWON
Author Information
1. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. m1fenew@hanmail.net
- Publication Type:Original Article
- Keywords:
Pancreatic adenocarcinoma;
Transcatheter arterial chemoembolization;
Liver
- MeSH:
Adenocarcinoma;
Angiography;
Humans;
Liver;
Recurrence
- From:Gut and Liver
2010;4(3):384-388
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: Despite curative resection, hepatic recurrences cause a significant reduction in survival in patients with primary pancreatic adenocarcinoma. Transcatheter arterial chemoembolization (TACE) has recently been used successfully to treat primary and secondary hepatic malignancy. METHODS: Between 2003 and 2008, 15 patients underwent TACE because of hepatic recurrence after curative resection of a pancreatic adenocarcinoma. The tumor response was evaluated based on computed tomography scans after TACE. The overall duration of patient survival was measured. RESULTS: After TACE, a radiographically evident response occurred in six patients whose tumors demonstrated a tumor blush on angiography. Four patients demonstrated stabilization of a hypovascular mass. The remaining five patients demonstrated continued progression of hypovascular hepatic lesions. The median survival periods from the time of diagnosis and from the time of initial TACE were 9.6 and 7.5 months, respectively. CONCLUSIONS: TACE may represent a viable therapeutic modality in patients with hepatic recurrence after curative resection of pancreatic adenocarcinoma.
